323 related articles for article (PubMed ID: 21653960)
21. No, Chagas disease is not the new AIDS of the Americas!
Pays JF
Bull Soc Pathol Exot; 2012 Dec; 105(5):337-48. PubMed ID: 23104103
[TBL] [Abstract][Full Text] [Related]
22. Introducing new vaccines into developing countries: obstacles, opportunities and complexities.
Clemens J; Jodar L
Nat Med; 2005 Apr; 11(4 Suppl):S12-5. PubMed ID: 15812482
[TBL] [Abstract][Full Text] [Related]
23. Serving the world's poor, profitably.
Prahalad CK; Hammond A
Harv Bus Rev; 2002 Sep; 80(9):48-57, 124. PubMed ID: 12227146
[TBL] [Abstract][Full Text] [Related]
24. Why Funding for Neglected Tropical Diseases Should Be a Global Priority.
Reed SL; McKerrow JH
Clin Infect Dis; 2018 Jul; 67(3):323-326. PubMed ID: 29688342
[TBL] [Abstract][Full Text] [Related]
25. Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis.
Boelaert M; Meheus F; Robays J; Lutumba P
Ann Trop Med Parasitol; 2010 Oct; 104(7):535-42. PubMed ID: 21092391
[TBL] [Abstract][Full Text] [Related]
26. The poverty-related neglected diseases: Why basic research matters.
Hotez PJ
PLoS Biol; 2017 Nov; 15(11):e2004186. PubMed ID: 29121043
[TBL] [Abstract][Full Text] [Related]
27. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
28. Neglected tropical diseases: moving beyond mass drug treatment to understanding the science.
Mahmoud A; Zerhouni E
Health Aff (Millwood); 2009; 28(6):1726-33. PubMed ID: 19887413
[TBL] [Abstract][Full Text] [Related]
29. Intersectoral approaches to neglected diseases.
Ault SK
Ann N Y Acad Sci; 2008; 1136():64-9. PubMed ID: 18579876
[TBL] [Abstract][Full Text] [Related]
30. Progress in public-private partnerships to fight neglected diseases.
Gustavsen K; Hanson C
Health Aff (Millwood); 2009; 28(6):1745-9. PubMed ID: 19887415
[TBL] [Abstract][Full Text] [Related]
31. Injuries in low- and middle-income countries: a neglected disease in global public health.
Hyder AA
Injury; 2013 May; 44(5):579-80. PubMed ID: 23375623
[No Abstract] [Full Text] [Related]
32. Research priorities for zoonoses and marginalized infections.
World Health Organization
World Health Organ Tech Rep Ser; 2012; (971):ix-xi, 1-119, 2 p following 119. PubMed ID: 23420951
[TBL] [Abstract][Full Text] [Related]
33. The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.
Pedrique B; Strub-Wourgaft N; Some C; Olliaro P; Trouiller P; Ford N; Pécoul B; Bradol JH
Lancet Glob Health; 2013 Dec; 1(6):e371-9. PubMed ID: 25104602
[TBL] [Abstract][Full Text] [Related]
34. Neglected tropical diseases: is it time to add Helicobacter pylori to the list?
Natuzzi E
Glob Health Promot; 2013 Sep; 20(3):47-8. PubMed ID: 23986381
[TBL] [Abstract][Full Text] [Related]
35. UK launches new initiative against neglected tropical diseases.
Moszynski P
BMJ; 2012 Jan; 344():e581. PubMed ID: 22271605
[No Abstract] [Full Text] [Related]
36. Spurring new research for neglected diseases.
Anderson GF
Health Aff (Millwood); 2009; 28(6):1750-9. PubMed ID: 19887416
[TBL] [Abstract][Full Text] [Related]
37. Taking health promotion on to the streets.
Filgueiras A
AIDS Action; 1992 Jun; (17):7. PubMed ID: 12285897
[TBL] [Abstract][Full Text] [Related]
38. Health and medical care in Ethiopia.
Hodes RM; Kloos H
N Engl J Med; 1988 Oct; 319(14):918-24. PubMed ID: 3419456
[TBL] [Abstract][Full Text] [Related]
39. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
40. Technical fixes and other problems in saving lives in the world's poorest countries.
Reich MR
J Public Health Policy; 1988; 9(1):92-103. PubMed ID: 3360918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
